Quantcast
Last updated on April 23, 2014 at 20:06 EDT

Latest Peptide YY Stories

2013-11-15 08:26:53

NaZura BioHealth Presents at 2014 Obesity Society's Annual Scientific Meeting SAN DIEGO, Nov. 15, 2013 /PRNewswire/ -- NaZura BioHealth today announced clinical study results indicating that activation of taste receptors in the lower gut can amplify the release of hormones involved in satiety and glucose regulation. In an oral presentation to be made today at the Obesity Society's Annual Scientific Meeting, principal investigator Steven R. Smith, MD will describe how NaZura's proprietary Gut...

2013-06-18 08:30:35

ALBANY, Ga., June 18, 2013 /PRNewswire/ -- A new study, released in the current British Journal of Nutrition, showed that consuming peanut butter or peanuts for breakfast can control blood sugar throughout most of the day, even after eating a high carbohydrate lunch. In addition to this "Second Meal Effect," peanuts and peanut butter caused a significant reduction in the desire to eat for up to 12 hours and a significant increase in the secretion of the hormone PYY that promotes...

2012-11-02 14:41:57

Bariatric surgery, which significantly curtails the amount of food a person can eat, is the most effective treatment against obesity and is being recognized as a potentially valuable tool in the fight against diabetes related to obesity. It is being performed on increasing numbers of people worldwide, including teenagers. Unfortunately, some types of bariatric surgery may also cause bone loss, a cause for concern, particularly when carried out on young people who have not yet reached their...

Hormone-Laced Gum Could Lead To Weight Loss
2011-11-22 06:32:11

Recent research out of Syracuse University could lead to a specially-designed chewing gum that could deliver an appetite suppressant and, if chewed after meals, help individuals lose weight. The study, which was published on November 4 in the online edition of the Journal of Medicinal Chemistry and was led by Robert Doyle, an associate professor in the university's Department of Chemistry, centers around oral delivery of a hormone that helps make people full. According to a Monday press...

2011-11-03 17:00:00

THE WOODLANDS, Texas, Nov. 3, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that Dr. David Powell, senior vice president of metabolism research, will present data from clinical and preclinical studies of LX4211, a dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2), at the Cambridge Healthtech Institute's Diabetes Drug Discovery conference...

2009-11-04 13:06:19

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), eating a meal quickly, as compared to slowly, curtails the release of hormones in the gut that induce feelings of being full. The decreased release of these hormones, can often lead to overeating. "Most of us have heard that eating fast can lead to food overconsumption and obesity, and in fact some observational studies have supported this notion," said...

2008-12-17 21:57:56

For those who want to lose weight, aerobic exercise is better at suppressing appetite than non-aerobic exercise, British researchers have found. David J. Stensel of Loughborough University in England and colleagues said a vigorous 60-minute workout on a treadmill affects the release of two key appetite hormones, ghrelin and peptide YY, while 90 minutes of weight lifting only affects the level of ghrelin. The researchers said ghrelin is the only hormone known to stimulate appetite, while...

83910ecb903350040a0e3f246feabb451
2008-12-11 12:02:45

A vigorous 60-minute workout on a treadmill affects the release of two key appetite hormones, ghrelin and peptide YY, while 90 minutes of weight lifting affects the level of only ghrelin, according to a new study. Taken together, the research shows that aerobic exercise is better at suppressing appetite than non-aerobic exercise and provides a possible explanation for how that happens. This line of research may eventually lead to more effective ways to use exercise to help control weight,...

2008-08-01 12:00:28

MDRNA has announced results from a Phase II clinical trial evaluating PYY nasal spray for the treatment of obesity. The data indicate that PYY did not meet the primary efficacy endpoint of a dose response of weight loss versus PYY dose, nor did PYY meet the secondary efficacy endpoint of greater weight loss than the active control, sibutramine. The 24-week, blinded, randomized, placebo-controlled dose-ranging trial in healthy obese patients evaluated three different doses of PYY nasal...

2008-07-31 18:00:20

MDRNA, Inc. (Nasdaq: MRNA) announced today results from a Phase 2 clinical trial evaluating PYY(3-36) Nasal Spray (PYY) for the treatment of obesity. The data indicate that PYY did not meet the primary efficacy endpoint of a dose response of weight loss vs. PYY dose, nor did PYY meet the secondary efficacy endpoint of greater weight loss than the active control, sibutramine (Meridia(R)). "The study demonstrates that our tight junction technology effectively delivers PYY into the body via...